标题
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
作者
关键词
-
出版物
Nature Reviews Cardiology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-03-30
DOI
10.1038/s41569-020-0348-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Vascular toxic effects of cancer therapies
- (2020) Joerg Herrmann Nature Reviews Cardiology
- Review of Bruton tyrosine kinase inhibitors for the treatment of relapsed or refractory mantle cell lymphoma
- (2019) C. Owen et al. Current Oncology
- Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association
- (2019) Susan C. Gilchrist et al. CIRCULATION
- Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
- (2019) Joe-Elie Salem et al. NEW ENGLAND JOURNAL OF MEDICINE
- A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia
- (2019) Andrea Visentin et al. HEMATOLOGICAL ONCOLOGY
- Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study
- (2018) Inhye E. Ahn et al. BLOOD
- Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque–triggered thrombus formation in humans
- (2018) Kristina Busygina et al. BLOOD
- Ibrutinib-related bleeding
- (2018) Carlos Aguilar BLOOD COAGULATION & FIBRINOLYSIS
- Increased Susceptibility for Atrial and Ventricular Cardiac Arrhythmias in Mice Treated With a Single High Dose of Ibrutinib
- (2018) Jari M. Tuomi et al. CANADIAN JOURNAL OF CARDIOLOGY
- Cardiac Complications Associated With Checkpoint Inhibition: A Systematic Review of the Literature in an Important Emerging Area
- (2018) Hassan Mir et al. CANADIAN JOURNAL OF CARDIOLOGY
- Establishing an Evidence-Based Method to Diagnose Cardiac Sarcoidosis
- (2018) Edward J. Miller et al. Circulation-Cardiovascular Imaging
- FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer
- (2018) Anand Shah et al. CLINICAL CANCER RESEARCH
- Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices
- (2018) Daniele Pastori et al. Clinical Research in Cardiology
- Cardiotoxicities Associated with Immune Checkpoint Inhibitors
- (2018) Shu Yang et al. CURRENT PROBLEMS IN CANCER
- Treating cardiovascular complications of radiotherapy: a role for new pharmacotherapies
- (2018) Nathalie Donis et al. EXPERT OPINION ON PHARMACOTHERAPY
- How to prevent and manage radiation-induced coronary artery disease
- (2018) Jason R Cuomo et al. HEART
- A global perspective on vasoactive agents in shock
- (2018) Djillali Annane et al. INTENSIVE CARE MEDICINE
- Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity
- (2018) Mônica Samuel Avila et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events
- (2018) Rhian M. Touyz et al. Journal of the American Society of Hypertension
- Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System
- (2018) Connie Cheng et al. LEUKEMIA & LYMPHOMA
- Kinase-targeted cancer therapies: progress, challenges and future directions
- (2018) Khushwant S. Bhullar et al. Molecular Cancer
- Cardiorenal complications of immune checkpoint inhibitors
- (2018) Krishna Sury et al. Nature Reviews Nephrology
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- New-Onset Heart Failure and Mortality in Hospital Survivors of Sepsis-Related Left Ventricular Dysfunction
- (2018) Saraschandra Vallabhajosyula et al. SHOCK
- Takotsubo-Like Syndrome in Cancer Patients Treated With Immune Checkpoint Inhibitors
- (2018) Stephane Ederhy et al. JACC-Cardiovascular Imaging
- Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes (SUCCOUR) Trial
- (2018) Tomoko Negishi et al. JACC-Cardiovascular Imaging
- Exercise Training and Cardiovascular Health in Cancer Patients
- (2018) Ray W. Squires et al. Current Oncology Reports
- CARs versus BiTEs: A Comparison between T Cell–Redirection Strategies for Cancer Treatment
- (2018) Clare Y. Slaney et al. Cancer Discovery
- CHA2DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer
- (2018) Maria D’Souza et al. European Journal of Preventive Cardiology
- Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study
- (2018) Maria Cristina Vedovati et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
- (2018) Sana M. Al-Khatib et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Immune Checkpoint Inhibitor Toxicity
- (2018) David J. Palmieri et al. Current Oncology Reports
- Trastuzumab in Female Breast Cancer Patients With Reduced Left Ventricular Ejection Fraction
- (2018) Somaira Nowsheen et al. Journal of the American Heart Association
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer
- (2018) Wesley T. O’Neal et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women
- (2017) Haruki Sekiguchi et al. HEART
- Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)
- (2017) Hiromi Watanabe et al. INTERNAL MEDICINE
- Association Between Use of Antithrombotic Medication and Hematuria-Related Complications
- (2017) Christopher J. D. Wallis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity
- (2017) Edith Pituskin et al. JOURNAL OF CLINICAL ONCOLOGY
- A Perfect Storm: Tyrosine Kinase Inhibitor-Associated Polymorphic Ventricular Tachycardia
- (2017) Alexander Beyer et al. JOURNAL OF EMERGENCY MEDICINE
- Ventricular Tachycardia Caused by Ibrutinib
- (2017) János Tomcsányi et al. JOURNAL OF EMERGENCY MEDICINE
- Two Cases of Sinusitis Induced by Immune Checkpoint Inhibition
- (2017) Eric Dein et al. JOURNAL OF IMMUNOTHERAPY
- Cardiovascular Complications of Cancer Therapy
- (2017) Hui-Ming Chang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2017) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ibrutinib-associated bleeding: pathogenesis, management and risk reduction strategies
- (2017) J. J. Shatzel et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Anticoagulation prescribing patterns in patients with cancer
- (2017) Elaine Xiang et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Heart in space: effect of the extraterrestrial environment on the cardiovascular system
- (2017) Richard L. Hughson et al. Nature Reviews Cardiology
- Chimeric antigen receptor T-cell therapies for lymphoma
- (2017) Jennifer N. Brudno et al. Nature Reviews Clinical Oncology
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia
- (2017) Phillip S. Cuculich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma
- (2017) Ashley Ghiaseddin et al. ONCOLOGIST
- High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells
- (2017) Arun Sharma et al. Science Translational Medicine
- Use of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Malignancy: Clinical Practice Experience in a Single Institution and Literature Review
- (2017) Anna Rago et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Deconvoluting Kinase Inhibitor Induced Cardiotoxicity
- (2017) Sarah D. Lamore et al. TOXICOLOGICAL SCIENCES
- Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor Inhibition
- (2017) Timothy J. Stuhlmiller et al. Journal of the American Heart Association
- Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
- (2017) Andreu Porta‐Sánchez et al. Journal of the American Heart Association
- Ablative Radiotherapy as a Noninvasive Alternative to Catheter Ablation for Cardiac Arrhythmias
- (2017) Paul C. Zei et al. Current Cardiology Reports
- Cardiovascular Toxicities Associated with Cancer Immunotherapies
- (2017) Daniel Y. Wang et al. Current Cardiology Reports
- Mechanistic Systems Modeling to Improve Understanding and Prediction of Cardiotoxicity Caused by Targeted Cancer Therapeutics
- (2017) Jaehee V. Shim et al. Frontiers in Physiology
- Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
- (2017) I. Puzanov et al. Journal for ImmunoTherapy of Cancer
- Toxicities of chimeric antigen receptor T cells: recognition and management
- (2016) Jennifer N. Brudno et al. BLOOD
- The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis
- (2016) Darryl P. Leong et al. BLOOD
- Atrial fibrillation, anticoagulant stroke prophylaxis and bleeding risk with ibrutinib therapy for chronic lymphocytic leukaemia and lymphoproliferative disorders
- (2016) Stephen P. Mulligan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study
- (2016) Philip A. Thompson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity
- (2016) Wen Wee Ma et al. CANCER
- Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States
- (2016) S. M. Bluethmann et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy
- (2016) Thomas K. Eigentler et al. CANCER TREATMENT REVIEWS
- Management of toxicities of immune checkpoint inhibitors
- (2016) Lavinia Spain et al. CANCER TREATMENT REVIEWS
- SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa interve
- (2016) Cezar A. Iliescu et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Comparison of Acalabrutinib, A Selective Bruton Tyrosine Kinase Inhibitor, with Ibrutinib in Chronic Lymphocytic Leukemia Cells
- (2016) Viralkumar Patel et al. CLINICAL CANCER RESEARCH
- Cardiovascular Toxicities of Small Molecule Tyrosine Kinase Inhibitors: An Opportunity for Systems-Based Approaches
- (2016) S-A Brown et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy
- (2016) Yong-Joon Lee et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial
- (2016) Martine Piccart-Gebhart et al. JOURNAL OF CLINICAL ONCOLOGY
- The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy
- (2016) Raymond R. Russell et al. JOURNAL OF NUCLEAR CARDIOLOGY
- Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL)
- (2016) Tait D. Shanafelt et al. LEUKEMIA & LYMPHOMA
- Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
- (2016) Paul W Burridge et al. NATURE MEDICINE
- Induced pluripotent stem cells: at the heart of cardiovascular precision medicine
- (2016) Ian Y. Chen et al. Nature Reviews Cardiology
- Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
- (2016) Celine Boutros et al. Nature Reviews Clinical Oncology
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue
- (2016) Fabian Jacob et al. PLoS One
- Tyrosine Kinase Inhibitors and Vascular Toxicity: Impetus for a Classification System?
- (2016) Joerg Herrmann Current Oncology Reports
- Toxicity and management in CAR T-cell therapy
- (2016) Challice L Bonifant et al. Molecular Therapy-Oncolytics
- Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer
- (2016) Annelies H. Boekhout et al. JAMA Oncology
- Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation
- (2016) David Conen et al. JAMA Cardiology
- Paradigm Shift in Radiation Biology/Radiation Oncology—Exploitation of the “H2O2 Effect” for Radiotherapy Using Low-LET (Linear Energy Transfer) Radiation such as X-rays and High-Energy Electrons
- (2016) Yasuhiro Ogawa Cancers
- Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer
- (2016) Therese Franco Therapeutics and Clinical Risk Management
- Drug-induced mitochondrial dysfunction and cardiotoxicity
- (2015) Zoltán V Varga et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer
- (2015) Anthony F. Yu et al. BREAST CANCER RESEARCH AND TREATMENT
- FDA Approval: Blinatumomab
- (2015) D. Przepiorka et al. CLINICAL CANCER RESEARCH
- Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors
- (2015) Konrad Urbanek et al. CURRENT DRUG TARGETS
- Cancer Chemotherapy and Cardiac Arrhythmias: A Review
- (2015) Juan Tamargo et al. DRUG SAFETY
- Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
- (2015) Nabil Ahmed et al. JOURNAL OF CLINICAL ONCOLOGY
- ATRIAL FIBRILLATION AFTER THORACIC RADIOTHERAPY FOR CANCER: EXAMINING DIFFERENCES IN CLINICAL CHARACTERISTICS AT TIME OF DIAGNOSIS COMPARED WITH THE GENERAL POPULATION
- (2015) Vaibhav Vaidya et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab
- (2015) Timothy C. Tan et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Diagnosis and Treatment of Chronic Myeloid Leukemia in 2015
- (2015) Philip A. Thompson et al. MAYO CLINIC PROCEEDINGS
- Cardiotoxicity of anticancer treatments
- (2015) Michael S. Ewer et al. Nature Reviews Cardiology
- Inflammation and the pathogenesis of atrial fibrillation
- (2015) Yu-Feng Hu et al. Nature Reviews Cardiology
- Systems biology approaches to adverse drug effects: the example of cardio-oncology
- (2015) Sherry-Ann Brown et al. Nature Reviews Clinical Oncology
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
- (2015) Sandra M. Swain et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Evolving Landscape of HER2 Targeting in Breast Cancer
- (2015) Mark M. Moasser et al. JAMA Oncology
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- Radiation-Induced Heart Disease: Pathologic Abnormalities and Putative Mechanisms
- (2015) Neil K. Taunk et al. Frontiers in Oncology
- Effects of 5-Fluorouracil on Morphology, Cell Cycle, Proliferation, Apoptosis, Autophagy and ROS Production in Endothelial Cells and Cardiomyocytes
- (2015) Chiara Focaccetti et al. PLoS One
- Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153
- (2015) Babak Baban et al. PLoS One
- Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
- (2014) Yoshihiko Ichikawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Trastuzumab-Associated Cardiac Events at 8 Years of Median Follow-Up in the Herceptin Adjuvant Trial (BIG 1-01)
- (2014) Evandro de Azambuja et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence, Management, and Clinical Consequences of QT Interval Prolongation During Treatment With Arsenic Trioxide
- (2014) Gail J. Roboz et al. JOURNAL OF CLINICAL ONCOLOGY
- Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2014) Juan Carlos Plana et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- The immune system and response to HER2-targeted treatment in breast cancer
- (2014) Giampaolo Bianchini et al. LANCET ONCOLOGY
- New-Onset Heart Failure in Association With Severe Hypertension During Trastuzumab Therapy
- (2014) Joerg Herrmann et al. MAYO CLINIC PROCEEDINGS
- Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology
- (2014) Joerg Herrmann et al. MAYO CLINIC PROCEEDINGS
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives
- (2014) Monica Lamberti et al. TOXICOLOGY LETTERS
- A comparison of cardiomyocyte cytotoxic mechanisms for 5-fluorouracil and its pro-drug capecitabine
- (2014) Mohammad Reza Eskandari et al. XENOBIOTICA
- A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
- (2014) Anne Polk et al. BMC Pharmacology & Toxicology
- Doxorubicin induces senescence and impairs function of human cardiac progenitor cells
- (2013) Elena Piegari et al. BASIC RESEARCH IN CARDIOLOGY
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
- (2013) G. P. Linette et al. BLOOD
- Understanding Radiation-induced Cardiovascular Damage and Strategies for Intervention
- (2013) F.A. Stewart et al. CLINICAL ONCOLOGY
- Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors
- (2013) Alberto Farolfi et al. HEART
- Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in Patients With Septic Shock
- (2013) Andrea Morelli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The heart of the matter: Protection of the myocardium from T cells
- (2013) Andrew H. Lichtman JOURNAL OF AUTOIMMUNITY
- Insights Into Onco-Cardiology
- (2013) Dimitrios Farmakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Expert Consensus for Multi-Modality Imaging Evaluation of Cardiovascular Complications of Radiotherapy in Adults: A Report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography
- (2013) Patrizio Lancellotti et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Trastuzumab Alters the Expression of Genes Essential for Cardiac Function and Induces Ultrastructural Changes of Cardiomyocytes in Mice
- (2013) M. Khair ElZarrad et al. PLoS One
- Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
- (2013) B. J. Cameron et al. Science Translational Medicine
- MAGE-A3-specific anticancer immunotherapy in the clinical practice
- (2013) Vincent G. Brichard et al. OncoImmunology
- Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
- (2012) G. Curigliano et al. ANNALS OF ONCOLOGY
- Takotsubo syndrome
- (2012) Mehmet A. Ozturk et al. BLOOD COAGULATION & FIBRINOLYSIS
- Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients
- (2012) Yu-feng Hu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Severe hypothyroidism presenting as myxedema coma in the postoperative period in a patient taking sunitinib: case report and review of literature
- (2012) Abhijit V. Lele et al. JOURNAL OF CLINICAL ANESTHESIA
- Takotsubo Syndrome in a Patient Treated With Sunitinib for Renal Cancer
- (2012) Gianmauro Numico et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis
- (2012) M. L. Tarrio et al. JOURNAL OF IMMUNOLOGY
- Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer
- (2012) Jersey Chen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
- (2012) E. J. A. Bowles et al. JNCI-Journal of the National Cancer Institute
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice
- (2011) Nasser Ghaly Yousif et al. BMC Cardiovascular Disorders
- Erythropoietin Preserves the Endothelial Differentiation Capacity of Cardiac Progenitor Cells and Reduces Heart Failure during Anticancer Therapies
- (2011) Melanie Hoch et al. Cell Stem Cell
- How to Interpret Elevated Cardiac Troponin Levels
- (2011) Vinay S. Mahajan et al. CIRCULATION
- Melphalan-Induced Supraventricular Tachycardia: Incidence and Risk Factors
- (2011) Victor Feliz et al. CLINICAL CARDIOLOGY
- Heart Failure Associated with Sunitinib: Lessons Learned from Animal Models
- (2011) Colin F. Greineder et al. CURRENT HYPERTENSION REPORTS
- Myocarditis or myocardial infarction? MRI can help
- (2011) D. P. O'Regan et al. HEART
- Late calcification of the mitral–aortic junction causing transient complete atrio-ventricular block after mediastinal radiation of Hodgkin lymphoma: Multimodal visualization
- (2011) Francesco Santoro et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Takotsubo Cardiomyopathy and Fluorouracil: Case Report and Review of the Literature
- (2011) Michael R. Grunwald et al. JOURNAL OF CLINICAL ONCOLOGY
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- 5-Fluorouracil–Induced Tako-Tsubo–Like Syndrome
- (2011) Cécile Basselin et al. PHARMACOTHERAPY
- A Multifaceted Evaluation of Imatinib-induced Cardiotoxicity in the Rat
- (2011) Eugene H. Herman et al. TOXICOLOGIC PATHOLOGY
- Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina
- (2010) T. Stewart et al. INTERNAL MEDICINE JOURNAL
- Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
- (2010) Daniela Cardinale et al. JOURNAL OF CLINICAL ONCOLOGY
- Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies
- (2010) Armin Wolf et al. LEUKEMIA RESEARCH
- A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib
- (2010) Zahra Raisi Estabragh et al. LEUKEMIA RESEARCH
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
- (2010) Michael S. Ewer et al. Nature Reviews Cardiology
- The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro
- (2010) Brian B. Hasinoff et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity
- (2010) Brian B. Hasinoff TOXICOLOGY AND APPLIED PHARMACOLOGY
- Reduced Phosphoinositide 3-Kinase (p110α) Activation Increases the Susceptibility to Atrial Fibrillation
- (2009) Lynette Pretorius et al. AMERICAN JOURNAL OF PATHOLOGY
- Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
- (2009) G. Di Lorenzo et al. ANNALS OF ONCOLOGY
- 5 flourouracil-induced apical ballooning syndrome: a case report
- (2009) Monica Gianni et al. BLOOD COAGULATION & FIBRINOLYSIS
- Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function
- (2009) Antonella De Angelis et al. CIRCULATION
- Coronary Vasospasm with Myocardial Stunning in a Patient with Colon Cancer Receiving Adjuvant Chemotherapy with FOLFOX Regimen
- (2009) Jan Cerny et al. Clinical Colorectal Cancer
- Recovery From Anthracycline Cardiomyopathy After Long-term Support With a Continuous Flow Left Ventricular Assist Device
- (2009) Mark Freilich et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Myocarditis
- (2009) Leslie T. Cooper NEW ENGLAND JOURNAL OF MEDICINE
- A Case of Takotsubo Cardiomyopathy During 5-Fluorouracil Treatment for Rectal Adenocarcinoma
- (2009) Nobuaki Kobayashi et al. JOURNAL OF NIPPON MEDICAL SCHOOL
- Anthracycline Cardiotoxicity: From Bench to Bedside
- (2008) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
- An evaluation of the cardiotoxicity of imatinib mesylate
- (2008) Antonio Luiz Ribeiro et al. LEUKEMIA RESEARCH
- Mechanisms of Myocyte Cytotoxicity Induced by the Multiple Receptor Tyrosine Kinase Inhibitor Sunitinib
- (2008) B. B. Hasinoff et al. MOLECULAR PHARMACOLOGY
- Effect of the Multitargeted Tyrosine Kinase Inhibitors Imatinib, Dasatinib, Sunitinib, and Sorafenib on Mitochondrial Function in Isolated Rat Heart Mitochondria and H9c2 Cells
- (2008) Yvonne Will et al. TOXICOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now